BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29731023)

  • 1. Heart Failure With Preserved Ejection Fraction in Diabetes: Mechanisms and Management.
    Meagher P; Adam M; Civitarese R; Bugyei-Twum A; Connelly KA
    Can J Cardiol; 2018 May; 34(5):632-643. PubMed ID: 29731023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction.
    Paulus WJ; Dal Canto E
    JACC Heart Fail; 2018 Jan; 6(1):1-7. PubMed ID: 29284577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.
    Seferović PM; Paulus WJ
    Eur Heart J; 2015 Jul; 36(27):1718-27, 1727a-1727c. PubMed ID: 25888006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools.
    Pan KL; Hsu YC; Chang ST; Chung CM; Lin CL
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
    Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
    JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.
    Ter Maaten JM; Damman K; Verhaar MC; Paulus WJ; Duncker DJ; Cheng C; van Heerebeek L; Hillege HL; Lam CS; Navis G; Voors AA
    Eur J Heart Fail; 2016 Jun; 18(6):588-98. PubMed ID: 26861140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes.
    Mátyás C; Németh BT; Oláh A; Török M; Ruppert M; Kellermayer D; Barta BA; Szabó G; Kökény G; Horváth EM; Bódi B; Papp Z; Merkely B; Radovits T
    Eur J Heart Fail; 2017 Mar; 19(3):326-336. PubMed ID: 27995696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review.
    McHugh K; DeVore AD; Wu J; Matsouaka RA; Fonarow GC; Heidenreich PA; Yancy CW; Green JB; Altman N; Hernandez AF
    J Am Coll Cardiol; 2019 Feb; 73(5):602-611. PubMed ID: 30732715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction.
    Lam CS
    Diab Vasc Dis Res; 2015 Jul; 12(4):234-8. PubMed ID: 25908570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
    Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.
    Tschöpe C; Van Linthout S; Kherad B
    Curr Cardiol Rep; 2017 Aug; 19(8):70. PubMed ID: 28656481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
    Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competing risks of heart failure with preserved ejection fraction in diabetic patients.
    Takeda Y; Sakata Y; Mano T; Ohtani T; Kamimura D; Tamaki S; Omori Y; Tsukamoto Y; Aizawa Y; Komuro I; Yamamoto K
    Eur J Heart Fail; 2011 Jun; 13(6):664-9. PubMed ID: 21415098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
    Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
    J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed Repolarization Underlies Ventricular Arrhythmias in Rats With Heart Failure and Preserved Ejection Fraction.
    Cho JH; Zhang R; Kilfoil PJ; Gallet R; de Couto G; Bresee C; Goldhaber JI; Marbán E; Cingolani E
    Circulation; 2017 Nov; 136(21):2037-2050. PubMed ID: 28974519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension.
    van Heerebeek L; Hamdani N; Handoko ML; Falcao-Pires I; Musters RJ; Kupreishvili K; Ijsselmuiden AJ; Schalkwijk CG; Bronzwaer JG; Diamant M; Borbély A; van der Velden J; Stienen GJ; Laarman GJ; Niessen HW; Paulus WJ
    Circulation; 2008 Jan; 117(1):43-51. PubMed ID: 18071071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Role do Mitochondria Have in Diastolic Dysfunction? Implications for Diabetic Cardiomyopathy and Heart Failure With Preserved Ejection Function.
    McCandless MG; Altara R; Booz GW; Kurdi M
    J Cardiovasc Pharmacol; 2022 Apr; 79(4):399-406. PubMed ID: 35179855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Senescence Contributes to Heart Failure With Preserved Ejection Fraction in an Aging Mouse Model.
    Gevaert AB; Shakeri H; Leloup AJ; Van Hove CE; De Meyer GRY; Vrints CJ; Lemmens K; Van Craenenbroeck EM
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.
    D'Elia E; Vaduganathan M; Gori M; Gavazzi A; Butler J; Senni M
    Eur J Heart Fail; 2015 Dec; 17(12):1231-9. PubMed ID: 26493383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.